MUCPHARM EUROPE LIMITED

Overview

Mucpharm Europe Limited is a pharmaceutical company based in Ireland, operating under the CRO number 659445. The company focuses on developing treatments for diseases with unmet medical needs, particularly in oncology, respiratory conditions, and infections. Its core product, BromAc®, is being evaluated in clinical phases for use in oncology, respiratory disorders, and infections. The company has entered phase 2 clinical trials for intratumoral and intraperitoneal administration of BromAc® in pseudomyxoma peritonei and is advancing studies on its use in combination with chemotherapy and targeted therapies. It holds orphan designations from the US FDA and EMA for peritoneal mucinous tumors. Research also includes phase 1 safety data in respiratory applications, particularly in muco-obstructive conditions and ventilated patients. The company highlights synergies between BromAc® and existing treatments. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

2 Bella Vista Lodge

Off Butterfield Avenue

Rathfarnham Dublin 14 D14 K2T9

Rathfarnham

Dublin

Ireland

Industry classification

NACE Rev. 2 — 96.09

→ All NACE 96.09 companies in Ireland · In Dublin